检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杜春晓[1] 蒋倩[1] DU Chunxiao;JIANG Qian(Sichuan Cancer Hospital,Chengdu,610041)
机构地区:[1]四川省肿瘤医院
出 处:《实用癌症杂志》2020年第2期256-258,266,共4页The Practical Journal of Cancer
基 金:四川省卫生厅科研课题(编号:145547)
摘 要:目的探讨多西他赛联合卡培他滨治疗复发转移性乳腺癌的疗效及对CEA、CA199的影响。方法选取74例复发转移性乳腺癌患者,随机将其分为治疗组和对照组,各37例。对照组采用卡培他滨进行治疗,治疗组采用多西他赛联合卡培他滨治疗。对比两组患者的临床治疗效果。结果治疗组的总有效率和疾病控制率均均明显高于对照组(P<0.05);治疗组的血小板减少、WBC减少、脱发发生率明显低于对照组(P<0.05);两组患者治疗后的血清CEA、CA199水平均明显较治疗前低(P<0.05),但治疗组的血清CEA、CA199水平明显低于对照组(P<0.05)。结论多西他赛联合卡培他滨治疗复发转移性乳腺癌效果显著,可以提高临床疗效,降低不良反应发生率和血清CEA、CA199水平,值得在临床中应用推广。Objective To explore the efficacy of docetaxel combined with capecitabine in the treatment of recurrent metastatic breast cancer and its effect on serum CEA and CA199 levels.Methods 74 patients with recurrent metastatic breast cancer were randomly divided into the treatment group and the control group,37 cases in each group.The control group was treated with capecitabine,the treatment group was treated with docetaxel combined with capecitabine.The clinical therapeutic efficacy of the 2 groups were compared.Results The total effective rate and disease control rate of the treatment group were significantly higher than those of the control group(P<0.05);The thrombocytopenia,reduction of WBC and incidence of alopecia of the treatment group were significantly lower than those of the control group(P<0.05);The serum CEA and CA199 levels of the 2 groups before treatment was significantly lower than that after treatment(P<0.05),and the serum CEA and CA199 levels of the treatment group were significantly lower than those of the control group(P<0.05).Conclusion Docetaxel combined with capecitabine in the treatment of recurrent metastatic breast cancer is effective,which can improve the clinical efficacy,decrease incidence of adverse reactions and serum CEA and CA199 levels,and is worth popularizing in clinical practice.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222